By Nicholas Hatcher
Eli Lilly Chief Executive David Ricks said manufacturing of certain drugs could come back to the U.S. if there is an economic incentive, such as lower tax rates for domestic production.
"We favor carrots not sticks and would really like to see the tax bill passed, which would make permanent low tax rates in the U.S.," Ricks said Thursday on CNBC. "Particularly as the president says, 15% for domestic production would be one of the best in the world."
"The threat of tariffs is already bringing back critical supply chains in two important industries: chips and pharma," Ricks said Thursday.
The drugmaker reported surging quarterly revenue Thursday, on steady sales of Mounjaro and other weight-loss treatments. Adjusted earnings topped analyst estimates.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
May 01, 2025 08:00 ET (12:00 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。